Britain people positive fight partner Britain

AstraZeneca Begins Phase I Trial of COVID-19 Antibody Drug

Reading now: 577
toopanda.com

On Tuesday, August 25, 2020, a United Kingdom (UK)-based drug maker, AstraZeneca PLC (AstraZeneca) announced that it has started a Phase I clinical trial of its newly produced drug, known as AZD7442, to help prevent and treat COVID-19.

The trial is aimed to evaluate the safety, tolerability, and efficacy of the drug by performing a test of up to 48 healthy volunteers between the age group of 18 to 55 in the UK.The British pharmaceutical group said in a statement that the first participants have started receiving doses of AZD7442, a combination of two monoclonal antibodies (mAbs) for the trial.

Read more on toopanda.com
The website mental.guide is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.

Related articles

DMCA